Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata, this FDA Warning Letter issued to Hunan Norchem Pharmaceutical Co. Ltd. on January 9, 2018, concerns a pharmaceutical manufacturer, though the specific product category and nature of violations are not detailed in the available information. Without access to the full letter text or subject line, the exact regulatory concerns cannot be determined, though the warning indicates the company failed to meet FDA compliance standards in some aspect of its operations. The issuing office is not specified in the metadata, making it unclear which FDA division or geographic region initiated the action. Additional documentation would be needed to identify the specific violations and affected product lines.